Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker adherence in patients with primary versus secondary diagnosis of heart failure
Angiopoietin-2: Development of Inhibitors for Cancer Therapy
Angiogenesis inhibition: review of the activity of sorafenib, sunitinib and bevacizumab
Angiographic and Histologic Comparison of Injectable, Expansile Hydrogel Embolic and Pushable AZUR Embolic Devices in Porcine Arteries
Angiotensin II blockade: a strategy to slow ageing by protecting mitochondria?
Angiogenic and Inflammatory Markers of Cardiopulmonary Changes in Children and Adolescents with Sickle Cell Disease
Angiotensin II-Induced reactive oxygen species and the kidney
Angiogenesis Associated With Visceral and Subcutaneous Adipose Tissue in Severe Human Obesity
Angiogenesis as Prospective Molecular Biology Technique for Cancer Study
Angiotensin-converting enzyme inhibition and angiotensin AT(1)-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity
Angiopoietin-2 Primes Infection-Induced Preterm Delivery
Angiotensin II Regulates NOS Expression in Afferent Arterioles of the Developing Porcine Kidney
Angiopoietin-2 in CLL
Angiotensin II-induced hypertension dose-dependently leads to oxidative stress and DNA damage in mouse kidneys and hearts
Angina Symptoms Are Associated With Mortality in Older Women With Ischemic Heart Disease
Angiogenin: A Potential Serum Marker of Infantile Hemangioma Revealed by cDNA Microarray Analysis
Angioedema A class adverse effect of the angiotensin-converting enzyme inhibitors?
Angiotensin converting enzyme inhibitors and delayed onset, recurrent angioedema of the head and neck
Angioneurotic orolingual edema associated with the use of rt-PA following a stroke
Angiotensin-Converting Enzyme Inhibitors and Angioedema
Angioedema: A Review of 367 Episodes Presenting to Three Tertiary Care Hospitals
Angioedema: Differential diagnosis and treatment
Angioedema induced by angiotensin-converting enzyme inhibitors
Angioedema deaths in the United States, 1979-2010
Angiotensin II Induces Renal Plasminogen Activator Inhibitor-1 and Cyclooxygenase-2 Expression Post-Transcriptionally via Activation of the mRNA-Stabilizing Factor Human-Antigen R
Angiotensin type 1 receptor modulates macrophage polarization and renal injury in obesity
Angiotensin II and Its Role in Tubular Epithelial to Mesenchymal Transition Associated with Chronic Kidney Disease
Angioplasty of Below-the-elbow Arteries in Critical Hand Ischaemia
Angiotensin-converting enzyme limits inflammation elicited by Trypanosoma cruzi cysteine proteases: a peripheral mechanism regulating adaptive immunity via the innate kinin pathway
Angiotensin II induces mitochondrial oxidative stress and mtDNA damage in osteoblasts by inhibiting SIRT1-FoxO3a-MnSOD pathway
Angiogenesis and anti-angiogenesis
Angiotensin-(1-7) activates a tyrosine phosphatase and inhibits glucose-induced signalling in proximal tubular cells
Angiogenesis in Oral Lichen Planus: An In Vivo and Immunohistological Evaluation
Angiographic assessment of cardiac allograft vasculopathy: results of a Consensus Conference of the Task Force for Thoracic Organ Transplantation of the German Cardiac Society
Angiotensin Receptor Type 1 Single Nucleotide Polymorphism 1166A/C is Associated With Malignant Arrhythmias and Altered Circulating miR-155 Levels in Patients With Chronic Heart Failure
Angiotensin II stimulates superoxide production in the thick ascending limb by activating NOX4
Angiomatous meningiomas have a distinct genetic profile with multiple chromosomal polysomies including polysomy of chromosome 5
Angiotensin-(1-7) prevents radiation-induced inflammation in rat primary astrocytes through regulation of MAP kinase signaling
Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy
Angiotensin II type 1a receptor mediates doxorubicin-induced cardiomyopathy
Angiogenesis in hematologic malignancies
Angiogenesis and metastasis inhibitors for the treatment of malignant melanoma
Angiogenesis and antiangiogenic therapy of colon cancer liver metastasis
Angiogenesis, lymphangiogenesis, and melanoma metastasis
Angiogenesis in hematologic malignancies
Angiotensin II attenuates myocardial interstitial acetylcholine release in response to vagal stimulation
Angiotensin II induces leukocyte-endothelial cell interactions in vivo via AT(1) and AT(2) receptor-mediated P-selectin upregulation
Angiotensin II in septic shock
Angiotensin II induced catabolic effect and muscle atrophy are redox dependent
Angiotensin II-Dependent Superoxide Effects on Hypertension and Vascular Dysfunction
Angiotensin type-1-receptor antagonists reduce 6-hydroxydopamine toxicity for dopaminergic neurons
Angiotensin II-induced endothelin-1 release in cardiac myocytes.
Angiotensin I-converting enzyme inhibitor improves reactive hyperemia in elderly hypertensives with arteriosclerosis obliterans
Angiogenic targets for potential disorders
Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling
Angiotensin II and IGF-1 regulate connexin43 expression via ERK and p38 signaling pathways in of coronary artery vascular smooth muscle cells bypass conduits
Angiotensin II Activates Signal Transducers and Activators of Transcription 3 via Rac1 in the Atrial Tissue in Permanent Atrial Fibrillation Patients with Rheumatic Heart Disease
Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation
Angiotensin II activation of focal adhesion kinase and pp60(c-Src) in relation to mitogen-activated protein kinases in hepatocytes
Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide
Angiotensin II stimulates extracellular signal-regulated kinase activity in intact pressurized rat mesenteric resistance arteries
Angiotensin II initiates tyrosine kinase Pyk2-dependent signalings leading to activation of Rac1-mediated c-Jun NH2-terminal kinase
Angiotensin II-induced cardiac hypertrophy is associated with different mitogen-activated protein kinase activation in normotensive and hypertensive mice
Angiotensin converting enzyme inhibitors block mitogenic signalling pathways in rat cardiac fibroblasts
Angiotensin II activates MAPK and stimulates growth of human pulmonary artery smooth muscle via AT(1) receptors
Angiotensin II regulates phosphoinositide 3 kinase/Akt cascade via a negative crosstalk between AT(1) and AT(2) receptors in skin fibroblasts of human hypertrophic scars
Angiotensin II subtype 2 receptor activation inhibits insulin-induced phosphoinositide 3-kinase and Akt and induces apoptosis in PC12W cells
Angiotensin II regulates neuronal excitability via phosphatidylinositol 4,5-bisphosphate-dependent modulation of Kv7 (M-type) K+ channels
Angiotensin converting enzyme (ACE) inhibitory alkaloids from Fritillaria ussuriensis
Angiotensin II, Oxidative Stress and Skeletal Muscle Wasting
Angiotensin II inhibits the electrogenic NaH+/HCO3- cotransport of cat cardiac myocytes
Angiotensin II stimulation of VEGF mRNA translation requires production of reactive oxygen species
Angiotensin II and oxidative stress
Angiotensin II Promotes Thoracic Aortic Dissections and Ruptures in Col3a1 Haploinsufficient Mice
Angiostatic Factors in the Pulmonary Endarterectomy Material from Chronic Thromboembolic Pulmonary Hypertension Patients Cause Endothelial Dysfunction
Angiogenic/lymphangiogenic factors and adaptation to extreme altitudes during an expedition to Mount Everest
Angiogenic factors in the central nervous system - Comments
Angiogenesis inhibitors - A new class of drugs
Angiotensin II receptor blocker reduces oxidative stress and attenuates hypoxia-induced left ventricular remodeling in apolipoprotein E-knockout mice
Angiopoietin-1-induced phosphatidyl-inositol 3-kinase activation prevents neuronal apoptosis
Angiotensin II increases expression and secretion of cathepsin F in cultured human monocyte-derived macrophages: An angiotensin II type 2 receptor-mediated effect
Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats
Angiogenesis in implantation